TY - JOUR
T1 - Effective Therapy of Cilostazol in a Patient with Recurrent Ventricular Fibrillation Associated with Early Repolarization Pattern
AU - Iguchi, Kohei
AU - Noda, Takashi
AU - Miyamoto, Koji
AU - Yamada, Yuko
AU - Okamura, Hideo
AU - Satomi, Kazuhiro
AU - Aiba, Takeshi
AU - Shimizu, Wataru
AU - Aihara, Naohiko
AU - Kamakura, Shiro
PY - 2011
Y1 - 2011
N2 - Background: Efficacy of Quinidine was reported in patients with idiopathic ventricular fibrillation (VF) associated with early repolarization pattern on the electrogram. However, we experienced a case with recurrent VF associated with early repolarization pattern which was refractory to quinidine. Case: A 64-year-old woman was admitted to our hospital. Two years ago, she was diagnosed as idiopathic VF associated with early repolarization pattern and underwent implantable cardioverter-defibrillator (ICD) implantation. During follow-up period, ICD showed multiple VF episodes at early morning. Quinidine and bepridil were initiated but failed to prevent VF attacks. Ventricular pacing also could not suppress VF episodes. We tried cilostazol which was reported as an effective drug to prevent VF in Brugada syndrome. After cilostazol was initiated, no VF episodes were observed during her hospitalization and follow-up of 4 months.This case report demonstrated the efficacy of the cilostazol therapy to eliminate recurrent VF in a patient with early repolarization syndrome like Brugada syndrome.
AB - Background: Efficacy of Quinidine was reported in patients with idiopathic ventricular fibrillation (VF) associated with early repolarization pattern on the electrogram. However, we experienced a case with recurrent VF associated with early repolarization pattern which was refractory to quinidine. Case: A 64-year-old woman was admitted to our hospital. Two years ago, she was diagnosed as idiopathic VF associated with early repolarization pattern and underwent implantable cardioverter-defibrillator (ICD) implantation. During follow-up period, ICD showed multiple VF episodes at early morning. Quinidine and bepridil were initiated but failed to prevent VF attacks. Ventricular pacing also could not suppress VF episodes. We tried cilostazol which was reported as an effective drug to prevent VF in Brugada syndrome. After cilostazol was initiated, no VF episodes were observed during her hospitalization and follow-up of 4 months.This case report demonstrated the efficacy of the cilostazol therapy to eliminate recurrent VF in a patient with early repolarization syndrome like Brugada syndrome.
KW - VF
KW - cilostazol
KW - early repolarization
UR - http://www.scopus.com/inward/record.url?scp=85009644974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009644974&partnerID=8YFLogxK
U2 - 10.4020/jhrs.27.OP17_4
DO - 10.4020/jhrs.27.OP17_4
M3 - Article
AN - SCOPUS:85009644974
SN - 1880-4276
VL - 27
SP - 209
JO - Journal of Arrhythmia
JF - Journal of Arrhythmia
IS - 4
ER -